$71.67
0.11% yesterday
Nasdaq, Oct 17, 10:00 pm CET
ISIN
US8064071025
Symbol
HSIC

Henry Schein Stock price

$71.67
+0.43 0.60% 1M
+1.47 2.09% 6M
-4.04 5.34% YTD
+0.32 0.45% 1Y
-4.86 6.35% 3Y
+8.12 12.78% 5Y
+27.28 61.44% 10Y
Nasdaq, Closing price Thu, Oct 17 2024
-0.08 0.11%
ISIN
US8064071025
Symbol
HSIC
Sector

Key metrics

Market capitalization $9.08b
Enterprise Value $13.27b
P/E (TTM) P/E ratio 26.50
EV/FCF (TTM) EV/FCF 24.81
EV/Sales (TTM) EV/Sales 1.06
P/S ratio (TTM) P/S ratio 0.73
P/B ratio (TTM) P/B ratio 2.59
Revenue growth (TTM) Revenue growth -0.88%
Revenue (TTM) Revenue $12.49b
EBIT (operating result TTM) EBIT $605.00m
Free Cash Flow (TTM) Free Cash Flow $535.00m
Cash position $138.00m
EPS (TTM) EPS $2.71
P/E forward 20.79
P/S forward 0.70
EV/Sales forward 1.03
Short interest 5.64%
Show more

Is Henry Schein a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.

Henry Schein Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Henry Schein forecast:

5x Buy
36%
6x Hold
43%
3x Sell
21%

Analyst Opinions

14 Analysts have issued a Henry Schein forecast:

Buy
36%
Hold
43%
Sell
21%

Financial data from Henry Schein

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
12,487 12,487
1% 1%
100%
- Direct Costs 8,778 8,778
2% 2%
70%
3,709 3,709
1% 1%
30%
- Selling and Administrative Expenses 2,820 2,820
8% 8%
23%
- Research and Development Expense - -
-
-
889 889
16% 16%
7%
- Depreciation and Amortization 284 284
32% 32%
2%
EBIT (Operating Income) EBIT 605 605
28% 28%
5%
Net Profit 352 352
23% 23%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Henry Schein directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Henry Schein Stock News

Neutral
Accesswire
about 14 hours ago
GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks.
Neutral
Business Wire
9 days ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Milton that the Henry Schein Customer Assistance Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry ...
Neutral
Business Wire
15 days ago
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the opening of the Henry Schein Cares Foundation 2024 Relief Fund to support the Southeast U.S. Contributions will help ensure critical supplies and resources can help people impacted by Hurricane Helene. The Company and Henry Schein Cares Foundation will donate an initial $25,000 each to support relief efforts a...
More Henry Schein News

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Head office United States
CEO Stanley Bergman
Employees 25,000
Founded 1932
Website www.henryschein.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today